Ozempic-weight-loss
Ozempic-weight-loss

Use Cases

Simplifying Eligibility and Follow-Up in GLP-1 Treatments

Simplifying Eligibility and Follow-Up in GLP-1 Treatments

AI simplifies GLP-1 eligibility and follow-up, enabling quick approvals and continuous patient support for better treatment outcomes.

Luca Spektor

|

Aug 13, 2024

|

3

min read

About the Client:

Our client is a company in the GLP-1 treatment space, helping patients manage obesity and type 2 diabetes. They faced challenges in making sure the right patients were approved for treatment and in keeping those patients on track throughout their treatment journey.

Problem:

  1. Eligibility Confusion: Determining who qualifies for GLP-1 treatments was complicated. The process was slow and often inaccurate, frustrating patients and delaying care.

  2. Inconsistent Follow-Up: Once patients started treatment, many didn’t stick with it. Without proper follow-up, patients would miss doses, experience side effects without guidance, or stop treatment altogether.

Solution:

We introduced an AI-powered solution that automates the eligibility process and provides ongoing support to patients:

  • Automated Eligibility Checks: The AI asks patients simple, tailored questions to quickly determine if they qualify for treatment, cutting out the confusion and delays.

  • Continuous Support: The AI checks in with patients regularly, reminding them to take their medication, checking for side effects, and adjusting their treatment as needed. This keeps patients engaged and on track.

Front-End Embedding:

This AI solution was easily added to the client’s existing patient portal, making it simple for patients to interact with the AI as part of their routine.

Request a demo

Request a demo

Get custom pricing and become a part of the Puppeteer community

© 2024 Puppeteer. All rights reserved.

© 2024 Puppeteer. All rights reserved.

© 2024 Puppeteer. All rights reserved.